Oral Nutritional Supplementation in Cancer Patients Who Were Receiving Chemo/Chemoradiation Therapy: A Multicenter, Randomized Phase II Study

Supplementation in cancer patients receiving chemo or chemo/radiation therapy: A multicentric, randomized phase Ii study

Clinical Nutrition ◽

10.1016/j.clnu.2018.06.2082 ◽

2018 ◽

Vol 37 ◽

pp. S310

Author(s):

A.A. Faccio ◽

C. Mattos ◽

E.S. Santos ◽

N.R. Malta ◽

R.P. Moreira ◽

...

Keyword(s):

Radiation Therapy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

Annals of Oncology ◽

10.1093/annonc/mds132 ◽

2012 ◽

Vol 23 (12) ◽

pp. 3069-3074 ◽

Cited By ~ 94

Author(s):

E. Alba ◽

L. Calvo ◽

J. Albanell ◽

J.R. De la Haba ◽

A. Arcusa Lanza ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Neoadjuvant Treatment ◽

Luminal Breast Cancer ◽

Breast Cancer Patients ◽

P5-19-02: Comparison of the Incidence of Peripheral Neuropathy with Eribulin Mesylate Versus Ixabepilone in Metastatic Breast Cancer Patients: A Randomized Phase II Study.

10.1158/0008-5472.sabcs11-p5-19-02 ◽

2011 ◽

Author(s):

L Vahdat ◽

P Gopalakrishna ◽

AA Garcia ◽

C Vogel ◽

C Pellegrino ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Peripheral Neuropathy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Eribulin Mesylate ◽

PRELIMINARY RESULTS ON THE IMPACT OF HYPOFRACTIONATED RADIOTHERAPY IN CARDIAC TOXICITY (CARDIAC FUNCTION) IN EARLY STAGED LEFT SIDED BREAST CANCER PATIENTS: A PROSPECTIVE RANDOMIZED PHASE II STUDY

Radiotherapy and Oncology ◽

10.1016/s0167-8140(11)71807-2 ◽

2011 ◽

Vol 98 ◽

pp. S41 ◽

Author(s):

I. Fragkandrea-Nixon ◽

V. Kouloulias ◽

N. Mpaziotis ◽

S. Mpetsou ◽

A. Sotiropoulou-Lontou ◽

...

Keyword(s):

Breast Cancer ◽

Cardiac Function ◽

Cancer Patients ◽

Phase Ii ◽

Cardiac Toxicity ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Preliminary Results ◽

Randomized Phase Ii ◽

The Impact

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine

European Journal of Cancer ◽

10.1016/s0959-8049(16)31216-3 ◽

2015 ◽

Vol 51 ◽

pp. S432 ◽

Author(s):

B. Kim ◽

K.W. Lee ◽

M.J. Kim ◽

H.S. Han ◽

Y.L. Park ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Second Line ◽

Second Line Chemotherapy ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

Line Chemotherapy

Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients: A randomized phase II study

Cancer ◽

10.1002/(sici)1097-0142(19960115)77:2<344::aid-cncr18>3.0.co;2-1 ◽

1996 ◽

Vol 77 (2) ◽

pp. 344-351 ◽

Cited By ~ 115

Author(s):

Roberto Petrioli ◽

Bruno Frediani ◽

Antonio Manganelli ◽

Gabriele Barbanti ◽

Bruno De Capua ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Bladder Cancer ◽

Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients

Cancer Immunology Immunotherapy ◽

10.1007/s00262-019-02456-z ◽

2020 ◽

Vol 69 (3) ◽

pp. 383-397 ◽

Author(s):

Alessandra Battaglia ◽

Alexia Buzzonetti ◽

Marco Fossati ◽

Giovanni Scambia ◽

Andrea Fattorossi ◽

...

Keyword(s):

Ovarian Cancer ◽

Combination Therapy ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Immune Correlates ◽

REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan—Biomarker analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.3510 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 3510-3510 ◽

Cited By ~ 3

Author(s):

Yasushi Tsuji ◽

Kohei Shitara ◽

Takeharu Yamanaka ◽

Tadamichi Denda ◽

Katsunori Shinozaki ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Biomarker Analysis ◽

Reverse Sequence ◽

Previously Treated ◽

Colorectal Cancer Patients

Abstract P4-12-25: Randomized phase II study of pre-operative docetaxel, carboplatin with trastuzumab (TCH) and/or/lapatinib (L) in HER-2 positive (H+) breast cancer patients (BC pts). ICORG 10-05

10.1158/0008-5472.sabcs13-p4-12-25 ◽

2013 ◽

Cited By ~ 4

Author(s):

J Crown ◽

L Coate ◽

M Keane ◽

J Kennedy ◽

S O'Reilly ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Her 2

Abstract OT3-04-04: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies

10.1158/1538-7445.sabcs18-ot3-04-04 ◽

2019 ◽

Author(s):

N Vidula ◽

A Goga ◽

J Hwang ◽

MC Liu ◽

BH Park ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Chest Wall ◽

Phase Ii ◽

Phase Ii Study ◽

Breast Cancer Patients ◽

Randomized Phase Ii ◽

Correlative Studies